nach oben

Endocrine

Erschienen in:

24.11.2023 | Review

The collagen matrix regulates the survival and function of pancreatic islets

verfasst von: Yingying Zhu, Mei Yang, Wanli Xu, Yun Zhang, Linlin Pan, Lina Wang, Furong Wang, Yanting Lu

Erschienen in: Endocrine | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

The extracellular matrix (ECM) provides an appropriate microenvironment for many kinds of cells, including pancreatic cells. Collagens are the most abundant components of the ECM. Type I, IV, V and VI collagen has been detected in pancreatic islets, and each type plays important role in the proliferation, survival, function and differentiation of pancreatic cells. In some cases, collagens show behaviours similar to those of growth factors and regulate the biological behaviour of β cells by binding with certain growth factors, including IGFs, EGFs and FGFs. The transcriptional coactivator YAP/TAZ has been widely recognised as a mechanosensor that senses changes in the physical characteristics of the ECM and inhibition of YAP/TAZ enhances insulin production and secretion. Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterised by the destruction of insulin-producing β cells. The crosstalk between collagens and immune cells plays a key role in the development and differentiation of immune cells. Further, Supplementation with collagens during islet transplantation is a promising strategy for improving the quality of the islets. But, excessive collagen deposition results in pancreatic fibrosis and pancreatic carcinoma. Targeting inhibit Piezo, autophagy or IL-6 may reduce excessive collagen deposition-induced pancreatic fibrosis and pancreatic carcinoma. This review provides insights into the treatment of T1DM to prolong life expectancy and provides the potential targets for treating collagen deposition-induced pancreatic fibrosis and pancreatic carcinoma.

Graphical Abstract

S. Thipsawat, Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature. Diab Vasc. Dis. Res. 18(6), 14791641211058856 (2021). https://doi.org/10.1177/14791641211058856CrossRefPubMedPubMedCentral

A. Ramzy, D.M. Thompson, K.A. Ward-Hartstonge, S. Ivison, L. Cook, R.V. Garcia, J. Loyal, P.T.W. Kim, G.L. Warnock, M.K. Levings, T.J. Kieffer, Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell 28(12), 2047–2061 (2021). https://doi.org/10.1016/j.stem.2021.10.003CrossRefPubMed

J.C. Valdoz, B.C. Johnson, D.J. Jacobs, N.A. Franks, E.L. Dodson, C. Sanders, C.G. Cribbs, P.M. Van Ry, The ECM: to Scaffold, or Not to Scaffold, that is the question. Int. J. Mol. Sci. 22(23), 12690 (2021). https://doi.org/10.3390/ijms222312690CrossRefPubMedPubMedCentral

L.A. Llacua, B.J. de Haan, P. de Vos, Laminin and collagen IV inclusion in immunoisolating microcapsules reduces cytokine-mediated cell death in human pancreatic islets. J. Tissue Eng. Regen. Med. 12(2), 460–467 (2018). https://doi.org/10.1002/term.2472CrossRefPubMed

L.A. Llacua, M.M. Faas, P. de Vos, Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. Diabetologia 61(6), 1261–1272 (2018). https://doi.org/10.1007/s00125-017-4524-8CrossRefPubMedPubMedCentral

Y. Zhu, S. Chen, W. Liu, F. Xu, J. Lu, T. Hayashi, K. Mizuno, S. Hattori, H. Fujisaki, T. Ikejima, IGF-1R/YAP signaling pathway is involved in collagen V-induced insulin biosynthesis and secretion in rat islet INS-1 cells. Connect. Tissue Res. 63(5), 498–513 (2022). https://doi.org/10.1080/03008207.2021.2025225CrossRefPubMed

Y. Zhu, W. Liu, S. Chen, F. Xu, L. Zhang, T. Hayashi, K. Mizuno, S. Hattori, H. Fujisaki, T. Ikejima, Collagen type I enhances cell growth and insulin biosynthesis in rat pancreatic cells. J. Mol. Endocrinol. 67(3), 135–148 (2021). https://doi.org/10.1530/JME-21-0032CrossRefPubMed

P. de Vos, M. Spasojevic, M.M. Faas, Treatment of diabetes with encapsulated islets. Adv. Exp. Med. Biol. 670, 38–53 (2010). https://doi.org/10.1007/978-1-4419-5786-3_5CrossRefPubMed

A. Llacua, B.J. de Haan, S.A. Smink, P. de Vos, Extracellular matrix components supporting human islet function in alginate-based immunoprotective microcapsules for treatment of diabetes. J. Biomed. Mater. Res. A 104(7), 1788–1796 (2016). https://doi.org/10.1002/jbm.a.35706CrossRefPubMed

10.

M.A. Kanak, M. Takita, T. Itoh, J.A. SoRelle, S. Murali, F. Kunnathodi, R. Shahbazov, M.C. Lawrence, M.F. Levy, B. Naziruddin, Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-kappaB inhibitors. Transplantation 98(5), 578–584 (2014). https://doi.org/10.1097/TP.0000000000000107CrossRefPubMedPubMedCentral

11.

M.Y. Donath, M. Boni-Schnetzler, H. Ellingsgaard, P.A. Halban, J.A. Ehses, Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol. Metab. 21(5), 261–267 (2010). https://doi.org/10.1016/j.tem.2009.12.010CrossRefPubMed

12.

C. Kuehn, P. Vermette, T. Fulop, Cross talk between the extracellular matrix and the immune system in the context of endocrine pancreatic islet transplantation. A review article. Pathol. Biol. 62(2), 67–78 (2014). https://doi.org/10.1016/j.patbio.2014.01.001CrossRefPubMed

13.

G.A. Di Lullo, S.M. Sweeney, J. Korkko, L. Ala-Kokko, J.D. San Antonio, Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J. Biol. Chem. 277(6), 4223–4231 (2002). https://doi.org/10.1074/jbc.M110709200CrossRefPubMed

14.

M. Musiime, J. Chang, U. Hansen, K.E. Kadler, C. Zeltz, D. Gullberg, Collagen assembly at the cell surface: dogmas revisited. Cells 10(3), 662 (2021). https://doi.org/10.3390/cells10030662CrossRefPubMedPubMedCentral

15.

E.S. Wijelath, S. Rahman, M. Namekata, J. Murray, T. Nishimura, Z. Mostafavi-Pour, Y. Patel, Y. Suda, M.J. Humphries, M. Sobel, Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ. Res. 99(8), 853–860 (2006). https://doi.org/10.1161/01.RES.0000246849.17887.66CrossRefPubMedPubMedCentral

16.

F.E. Smith, K.M. Rosen, L. Villa-Komaroff, G.C. Weir, S. Bonner-Weir, Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc. Natl. Acad. Sci. USA 88(14), 6152–6156 (1991). https://doi.org/10.1073/pnas.88.14.6152ADSCrossRefPubMedPubMedCentral

17.

G. Da Silva Xavier, Q. Qian, P.J. Cullen, G.A. Rutter, Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. Biochem. J. 377(Pt 1), 149–158 (2004). https://doi.org/10.1042/BJ20031260CrossRefPubMedPubMedCentral

18.

H. Tamemoto, T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa, Y. Terauchi, K. Ueki, Y. Kaburagi, S. Satoh et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372(6502), 182–186 (1994). https://doi.org/10.1038/372182a0ADSCrossRefPubMed

19.

E. Araki, M.A. Lipes, M.E. Patti, J.C. Bruning, B. Haag 3rd, R.S. Johnson, C.R. Kahn, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372(6502), 186–190 (1994). https://doi.org/10.1038/372186a0ADSCrossRefPubMed

20.

Y. Zhou, Q. Hu, F. Chen, J. Zhang, J. Guo, H. Wang, J. Gu, L. Ma, G. Ho, Human umbilical cord matrix-derived stem cells exert trophic effects on beta-cell survival in diabetic rats and isolated islets. Dis. Model Mech. 8(12), 1625–1633 (2015). https://doi.org/10.1242/dmm.021857CrossRefPubMedPubMedCentral

21.

X.Y. Li, S.Y. Wu, P.S. Leung, Human fetal bone marrow-derived mesenchymal stem cells promote the proliferation and differentiation of pancreatic progenitor cells and the engraftment function of islet-like cell clusters. Int. J. Mol. Sci. 20(17), 4083 (2019). https://doi.org/10.3390/ijms20174083CrossRefPubMedPubMedCentral

22.

A. Kharat, B. Chandravanshi, S. Gadre, V. Patil, R. Bhonde, A. Dubhashi, IGF-1 and somatocrinin trigger islet differentiation in human amniotic membrane derived mesenchymal stem cells. Life Sci. 216, 287–294 (2019). https://doi.org/10.1016/j.lfs.2018.11.028CrossRefPubMed

23.

A. Belfiore, R. Malaguarnera, M.L. Nicolosi, R. Lappano, M. Ragusa, A. Morrione, V. Vella, A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer. Cell Adh. Migr. 12(4), 305–314 (2018). https://doi.org/10.1080/19336918.2018.1445953CrossRefPubMedPubMedCentral

24.

R. Malaguarnera, M.L. Nicolosi, A. Sacco, A. Morcavallo, V. Vella, C. Voci, M. Spatuzza, S.Q. Xu, R.V. Iozzo, R. Vigneri, A. Morrione, A. Belfiore, Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses. Oncotarget 6(18), 16084–16105 (2015). https://doi.org/10.18632/oncotarget.3177CrossRefPubMedPubMedCentral

25.

Y. Zhu, S. Chen, W. Liu, L. Zhang, F. Xu, T. Hayashi, K. Mizuno, S. Hattori, H. Fujisaki, and T. Ikejima. Collagens I and V differently regulate the proliferation and adhesion of rat islet INS-1 cells through the integrin beta1/E-cadherin/beta-catenin pathway. Connect. Tissue Res. 1–13 (2020). https://doi.org/10.1080/03008207.2020.1845321.

26.

S. Surve, S.C. Watkins, A. Sorkin, EGFR-RAS-MAPK signaling is confined to the plasma membrane and associated endorecycling protrusions. J. Cell Biol. 220(11), 202107103 (2021). https://doi.org/10.1083/jcb.202107103CrossRef

27.

F. Guerra, S. Quintana, S. Giustina, G. Mendeluk, L. Jufe, M.A. Avagnina, L.B. Diaz, L.A. Palaoro, Investigation of EGFR/pi3k/Akt signaling pathway in seminomas. Biotech. Histochem. 96(2), 125–137 (2021). https://doi.org/10.1080/10520295.2020.1776393CrossRefPubMed

28.

H. Maachi, G. Fergusson, M. Ethier, G.N. Brill, L.S. Katz, L.B. Honig, M.R. Metukuri, D.K. Scott, J. Ghislain, V. Poitout, HB-EGF signaling is required for glucose-induced pancreatic beta-cell proliferation in rats. Diabetes 69(3), 369–380 (2020). https://doi.org/10.2337/db19-0643CrossRefPubMedPubMedCentral

29.

L. Yang, Y. Zhu, D. Kong, J. Gong, W. Yu, Y. Liang, Y. Nie, C.B. Teng, EGF suppresses the expression of miR-124a in pancreatic beta cell lines via ETS2 activation through the MEK and PI3K signaling pathways. Int. J. Biol. Sci. 15(12), 2561–2575 (2019). https://doi.org/10.7150/ijbs.34985CrossRefPubMedPubMedCentral

30.

A. Ardestani, S. Li, K. Annamalai, B. Lupse, S. Geravandi, A. Dobrowolski, S. Yu, S. Zhu, T.D. Baguley, M. Surakattula, J. Oetjen, L. Hauberg-Lotte, R. Herranz, S. Awal, D. Altenhofen, V. Nguyen-Tran, S. Joseph, P.G. Schultz, A.K. Chatterjee, N. Rogers, M.S. Tremblay, W. Shen, K. Maedler, Neratinib protects pancreatic beta cells in diabetes. Nat. Commun. 10(1), 5015 (2019). https://doi.org/10.1038/s41467-019-12880-5ADSCrossRefPubMedPubMedCentral

31.

T. Sarazin, G. Collin, E. Buache, L. Van Gulick, C. Charpentier, C. Terryn, H. Morjani, C. Saby, Type I collagen aging increases expression and activation of EGFR and induces resistance to Erlotinib in lung carcinoma in 3D matrix model. Front. Oncol. 10, 1593 (2020). https://doi.org/10.3389/fonc.2020.01593CrossRefPubMedPubMedCentral

32.

D. Nanba, F. Toki, K. Asakawa, H. Matsumura, K. Shiraishi, K. Sayama, K. Matsuzaki, H. Toki, E.K. Nishimura, EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 proteolysis. J. Cell Biol. 220(11), 202012073 (2021). https://doi.org/10.1083/jcb.202012073CrossRef

33.

A.F. Blandin, E. Cruz Da Silva, M.C. Mercier, O. Glushonkov, P. Didier, S. Dedieu, C. Schneider, J. Devy, N. Etienne-Selloum, M. Dontenwill, L. Choulier, M. Lehmann, Gefitinib induces EGFR and alpha5beta1 integrin co-endocytosis in glioblastoma cells. Cell Mol. Life Sci. 78(6), 2949–2962 (2021). https://doi.org/10.1007/s00018-020-03686-6CrossRefPubMed

34.

O. Tsaplina, E. Bozhokina, Bacterial outer membrane protein OmpX regulates beta1 integrin and Epidermal Growth Factor Receptor (EGFR) involved in invasion of M-HeLa cells by serratia proteamaculans. Int. J. Mol. Sci. 22(24), 13246 (2021). https://doi.org/10.3390/ijms222413246CrossRefPubMedPubMedCentral

35.

W. Baszanowska, M. Misiura, I. Oscilowska, J. Palka, W. Miltyk, Extracellular Prolidase (PEPD) induces anabolic processes through EGFR, beta1-integrin, and IGF-1R signaling pathways in an experimental model of wounded fibroblasts. Int. J. Mol. Sci. 22(2), 942 (2021). https://doi.org/10.3390/ijms22020942CrossRefPubMedPubMedCentral

36.

W. Sheng, C. Chen, M. Dong, G. Wang, J. Zhou, H. Song, Y. Li, J. Zhang, S. Ding, Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway. Cell Death Dis. 8(10), 3147 (2017). https://doi.org/10.1038/cddis.2017.547CrossRef

37.

A.K. Iyer, K.T. Tran, C.W. Borysenko, M. Cascio, C.J. Camacho, H.C. Blair, I. Bahar, A. Wells, Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J. Cell Physiol. 211(3), 748–758 (2007). https://doi.org/10.1002/jcp.20986CrossRefPubMed

38.

M.F. Brizzi, G. Tarone, P. Defilippi, Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr. Opin. Cell Biol. 24(5), 645–651 (2012). https://doi.org/10.1016/j.ceb.2012.07.001CrossRefPubMed

39.

L. Geng, K.S.L. Lam, A. Xu, The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat. Rev. Endocrinol. 16(11), 654–667 (2020). https://doi.org/10.1038/s41574-020-0386-0CrossRefPubMed

40.

M. Zhou, R.M. Learned, S.J. Rossi, A.M. DePaoli, H. Tian, L. Ling, Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. Hepatol. Commun. 1(10), 1024–1042 (2017). https://doi.org/10.1002/hep4.1108CrossRefPubMedPubMedCentral

41.

W. Lu, X. Li, Y. Luo, FGF21 in obesity and cancer: new insights. Cancer Lett. 499, 5–13 (2021). https://doi.org/10.1016/j.canlet.2020.11.026ADSCrossRefPubMed

42.

W.Y. So, Q. Cheng, A. Xu, K.S. Lam, P.S. Leung, Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death Dis. 6, 1707 (2015). https://doi.org/10.1038/cddis.2015.80CrossRef

43.

P.A. Kolodziejski, M. Sassek, J. Bien, N. Leciejewska, D. Szczepankiewicz, B. Szczepaniak, M. Wojciechowska, L. Nogowski, K.W. Nowak, M.Z. Strowski, E. Pruszynska-Oszmalek, FGF-1 modulates pancreatic beta-cell functions/metabolism: an in vitro study. Gen. Comp. Endocrinol. 294, 113498 (2020). https://doi.org/10.1016/j.ygcen.2020.113498CrossRefPubMed

44.

R. Dettmer, K. Cirksena, J. Munchhoff, J. Kresse, U. Diekmann, I. Niwolik, F.F.R. Buettner, O. Naujok, FGF2 inhibits early pancreatic lineage specification during differentiation of human embryonic stem cells. Cells 9(9), 1927 (2020). https://doi.org/10.3390/cells9091927CrossRefPubMedPubMedCentral

45.

S. Arnaud-Dabernat, M. Kritzik, A.G. Kayali, Y.Q. Zhang, G. Liu, C. Ungles, N. Sarvetnick, FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells. Diabetes 56(1), 96–106 (2007). https://doi.org/10.2337/db05-1073CrossRefPubMed

46.

T. Jia, E. Vaganay, G. Carpentier, P. Coudert, V. Guzman-Gonzales, R. Manuel, B. Eymin, J.L. Coll, F. Ruggiero, A collagen Valpha1-derived fragment inhibits FGF-2 induced-angiogenesis by modulating endothelial cells plasticity through its heparin-binding site. Matrix Biol. 94, 18–30 (2020). https://doi.org/10.1016/j.matbio.2020.07.001CrossRefPubMed

47.

J.C. Stendahl, D.B. Kaufman, S.I. Stupp, Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transpl. 18(1), 1–12 (2009). https://doi.org/10.3727/096368909788237195CrossRef

48.

J. Baek, K.I. Lee, H.J. Ra, M.K. Lotz, D.D. D’Lima, Collagen fibrous scaffolds for sustained delivery of growth factors for meniscal tissue engineering. Nanomedicine 17(2), 77–93 (2022). https://doi.org/10.2217/nnm-2021-0313CrossRefPubMedPubMedCentral

49.

R. Nakamura, T. Katsuno, M. Kitamura, M. Yamashita, T. Tsuji, R. Suzuki, Y. Kishimoto, A. Suehiro, I. Tateya, T. Nakamura, K. Omori, Collagen sponge scaffolds containing growth factors for the functional regeneration of tracheal epithelium. J. Tissue Eng. Regen. Med. 13(5), 835–845 (2019). https://doi.org/10.1002/term.2835CrossRefPubMed

50.

N. Nagy, G. Kaber, M.J. Kratochvil, H.F. Kuipers, S.M. Ruppert, K. Yadava, J. Yang, S.C. Heilshorn, S.A. Long, A. Pugliese, P.L. Bollyky, Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD mice. Diabetologia 64(1), 152–158 (2021). https://doi.org/10.1007/s00125-020-05314-1CrossRefPubMed

51.

A. Ardestani, K. Maedler, The hippo signaling pathway in pancreatic beta-Cells: functions and regulations. Endocr. Rev. 39(1), 21–35 (2018). https://doi.org/10.1210/er.2017-00167CrossRefPubMed

52.

T. Hasegawa, T. Sugihara, Y. Hoshino, R. Tarumoto, Y. Matsuki, T. Kanda, T. Takata, T. Nagahara, T. Matono, H. Isomoto, Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner. Oncol. Lett. 22(4), 703 (2021). https://doi.org/10.3892/ol.2021.12964CrossRefPubMedPubMedCentral

53.

A. Mamidi, C. Prawiro, P.A. Seymour, K.H. de Lichtenberg, A. Jackson, P. Serup, H. Semb, Mechanosignalling via integrins directs fate decisions of pancreatic progenitors. Nature 564(7734), 114–118 (2018). https://doi.org/10.1038/s41586-018-0762-2ADSCrossRefPubMed

54.

E.A. Rosado-Olivieri, K. Anderson, J.H. Kenty, D.A. Melton, YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing beta cells. Nat. Commun. 10(1), 1464 (2019). https://doi.org/10.1038/s41467-019-09404-6ADSCrossRefPubMedPubMedCentral

55.

N.M. George, C.E. Day, B.P. Boerner, R.L. Johnson, N.E. Sarvetnick, Hippo signaling regulates pancreas development through inactivation of Yap. Mol. Cell Biol. 32(24), 5116–5128 (2012). https://doi.org/10.1128/MCB.01034-12CrossRefPubMedPubMedCentral

56.

E. Rozengurt, J. Sinnett-Smith, G. Eibl, Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival. Signal. Transduct. Target Ther. 3, 11 (2018). https://doi.org/10.1038/s41392-017-0005-2CrossRefPubMedPubMedCentral

57.

M. Uhlen, C. Zhang, S. Lee, E. Sjostedt, L. Fagerberg, G. Bidkhori, R. Benfeitas, M. Arif, Z. Liu, F. Edfors, K. Sanli, K. von Feilitzen, P. Oksvold, E. Lundberg, S. Hober, P. Nilsson, J. Mattsson, J.M. Schwenk, H. Brunnstrom, B. Glimelius, T. Sjoblom, P.H. Edqvist, D. Djureinovic, P. Micke, C. Lindskog, A. Mardinoglu, F. Ponten, A pathology atlas of the human cancer transcriptome. Science 357(6352), 2507 (2017). https://doi.org/10.1126/science.aan2507CrossRef

58.

T. Panciera, L. Azzolin, M. Cordenonsi, S. Piccolo, Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 18(12), 758–770 (2017). https://doi.org/10.1038/nrm.2017.87CrossRefPubMedPubMedCentral

59.

M. Ohgushi, M. Minaguchi, Y. Sasai, Rho-signaling-directed YAP/TAZ activity underlies the long-term survival and expansion of human embryonic stem cells. Cell Stem Cell 17(4), 448–461 (2015). https://doi.org/10.1016/j.stem.2015.07.009CrossRefPubMed

60.

G. Halder, S. Dupont, S. Piccolo, Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 13(9), 591–600 (2012). https://doi.org/10.1038/nrm3416CrossRefPubMed

61.

X. Liu, X. Long, W. Liu, Y. Zhao, T. Hayashi, M. Yamato, K. Mizuno, H. Fujisaki, S. Hattori, S.I. Tashiro, T. Ogura, Y. Atsuzawa, T. Ikejima, Type I collagen induces mesenchymal cell differentiation into myofibroblasts through YAP-induced TGF-beta1 activation. Biochimie 150, 110–130 (2018). https://doi.org/10.1016/j.biochi.2018.05.005CrossRefPubMed

62.

Q. Xu, X. Liu, W. Liu, T. Hayashi, M. Yamato, H. Fujisaki, S. Hattori, S.I. Tashiro, S. Onodera, T. Ikejima, Type I collagen-induced YAP nuclear expression promotes primary cilia growth and contributes to cell migration in confluent mouse embryo fibroblast 3T3-L1 cells. Mol. Cell Biochem. 450(1-2), 87–96 (2019). https://doi.org/10.1007/s11010-018-3375-zCrossRefPubMed

63.

I. Afrikanova, M. Yebra, M. Simpkinson, Y. Xu, A. Hayek, A. Montgomery, Inhibitors of Src and focal adhesion kinase promote endocrine specification: impact on the derivation of beta-cells from human pluripotent stem cells. J. Biol. Chem. 286(41), 36042–36052 (2011). https://doi.org/10.1074/jbc.M111.290825CrossRefPubMedPubMedCentral

64.

D.L. Eizirik, L. Pasquali, M. Cnop, Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat. Rev. Endocrinol. 16(7), 349–362 (2020). https://doi.org/10.1038/s41574-020-0355-7CrossRefPubMed

65.

J. Ilonen, J. Lempainen, R. Veijola, The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 15(11), 635–650 (2019). https://doi.org/10.1038/s41574-019-0254-yCrossRefPubMed

66.

O. Skog, S. Korsgren, A. Melhus, O. Korsgren, Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr. Opin. Endocrinol. Diabetes Obes. 20(2), 118–123 (2013). https://doi.org/10.1097/MED.0b013e32835edb89CrossRefPubMed

67.

A.J. Dwyer, J.M. Ritz, J.S. Mitchell, T. Martinov, M. Alkhatib, N. Silva, C.G. Tucker, B.T. Fife, Enhanced CD4(+) and CD8(+) T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses. Sci. Rep. 11(1), 17142 (2021). https://doi.org/10.1038/s41598-021-96327-2ADSCrossRefPubMedPubMedCentral

68.

V.S. Kumawat, G. Kaur, Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. Eur. J. Pharm. 862, 172628 (2019). https://doi.org/10.1016/j.ejphar.2019.172628CrossRef

69.

Y. Peng, D. Wen, F. Lin, R.I. Mahato, Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice. J. Control. Release 292, 1–12 (2018). https://doi.org/10.1016/j.jconrel.2018.10.032CrossRefPubMed

70.

A.E. Ciecko, D.M. Schauder, B. Foda, G. Petrova, M.Y. Kasmani, R. Burns, C.W. Lin, W.R. Drobyski, W. Cui, Y.G. Chen, Self-renewing islet TCF1(+) CD8 T cells undergo IL-27-controlled differentiation to become TCF1(-) terminal effectors during the progression of Type 1 diabetes. J. Immunol. 207(8), 1990–2004 (2021). https://doi.org/10.4049/jimmunol.2100362CrossRefPubMed

71.

H. Sun, K. Zhi, L. Hu, Z. Fan, The activation and regulation of beta2 integrins in phagocytes and phagocytosis. Front. Immunol. 12, 633639 (2021). https://doi.org/10.3389/fimmu.2021.633639CrossRefPubMedPubMedCentral

72.

I. Mitroulis, V.I. Alexaki, I. Kourtzelis, A. Ziogas, G. Hajishengallis, T. Chavakis, Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol. Ther. 147, 123–135 (2015). https://doi.org/10.1016/j.pharmthera.2014.11.008CrossRefPubMed

73.

F. Lagarrigue, F.B. Gertler, M.H. Ginsberg, J.M. Cantor, Cutting edge: loss of T Cell RIAM precludes conjugate formation with APC and prevents immune-mediated diabetes. J. Immunol. 198(9), 3410–3415 (2017). https://doi.org/10.4049/jimmunol.1601743CrossRefPubMed

74.

Y. Zhang, R. Xie, H. Zhang, Y. Zheng, C. Lin, L. Yang, M. Huang, M. Li, F. Song, L. Lu, M. Yang, Y. Liu, Q. Wei, J. Li, J. Chen, Integrin beta7 inhibits colorectal cancer pathogenesis via maintaining antitumor immunity. Cancer Immunol. Res. 9(8), 967–980 (2021). https://doi.org/10.1158/2326-6066.CIR-20-0879CrossRefPubMed

75.

X. You, M. Pan, W. Gao, H.S. Shiah, J. Tao, D. Zhang, F. Koumpouras, S. Wang, H. Zhao, J.A. Madri, D. Baker, Y.C. Cheng, Z. Yin, Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. Arthritis Rheum. 54(3), 877–886 (2006). https://doi.org/10.1002/art.21640CrossRefPubMed

76.

K.J. Warrington, U. Nair, L.D. Carbone, A.H. Kang, A.E. Postlethwaite, Characterisation of the immune response to type I collagen in scleroderma. Arthritis Res. Ther. 8(4), R136 (2006). https://doi.org/10.1186/ar2025CrossRefPubMedPubMedCentral

77.

Y.L. Zhao, W.W. Liu, W. Liu, Z.Y. Lu, D.H. Xuan, X. Zhang, X.L. Liu, T. Hayashi, M. Yamato, T. Ogura, H. Fujisaki, S. Hattori, S.I. Tashiro, S. Onodera, T. Ikejima, Phorbol ester (PMA)-treated U937 cells cultured on type I collagen-coated dish express a lower production of pro-inflammatory cytokines through lowered ROS levels in parallel with cell aggregate formation. Int. Immunopharmacol. 55, 158–164 (2018). https://doi.org/10.1016/j.intimp.2017.12.013CrossRefPubMed

78.

L.A. Llacua, A. Hoek, B.J. de Haan, P. de Vos, Collagen type VI interaction improves human islet survival in immunoisolating microcapsules for treatment of diabetes. Islets 10(2), 60–68 (2018). https://doi.org/10.1080/19382014.2017.1420449CrossRefPubMedPubMedCentral

79.

D. Brandhorst, H. Brandhorst, S. Layland, S. Acreman, K. Schenke-Layland, P.R.V. Johnson, nBasement membrane proteins improve human islet survival in hypoxia: implications for islet inflammation. Acta Biomater. 137, 92–102 (2021). https://doi.org/10.1016/j.actbio.2021.10.013CrossRefPubMed

80.

Y. Zhu, S. Chen, W. Liu, L. Zhang, F. Xu, T. Hayashi, K. Mizuno, S. Hattori, H. Fujisaki, and T. Ikejima. Collagens I and V differently regulate the proliferation and adhesion of rat islet INS-1 cells through the integrin β1/E-cadherin/β-catenin pathway. Connect. Tissue Res. 1–13 (2020). https://doi.org/10.1080/03008207.2020.1845321.

81.

J. Yang, Y. Sun, X. Liu, F. Xu, W. Liu, T. Hayashi, Y. Imamura, K. Mizuno, S. Hattori, K. Tanaka, H. Fujisaki, S.I. Tashiro, S. Onodera, T. Ikejima, Silibinin’s regulation of proliferation and collagen gene expressions of rat pancreatic beta-cells cultured on types I and V collagen involves beta-catenin nuclear translocation. Connect. Tissue Res. 60(5), 463–476 (2019). https://doi.org/10.1080/03008207.2019.1593393CrossRefPubMed

82.

Y. Li, A.W. Frei, I.M. Labrada, Y. Rong, J.P. Liang, M.M. Samojlik, C. Sun, S. Barash, B.G. Keselowsky, A.L. Bayer, C.L. Stabler, Immunosuppressive PLGA TGF-beta1 microparticles induce polyclonal and antigen-specific regulatory T cells for local immunomodulation of allogeneic islet transplants. Front. Immunol. 12, 653088 (2021). https://doi.org/10.3389/fimmu.2021.653088CrossRefPubMedPubMedCentral

83.

G.F. Shpilsky, H. Takahashi, A. Aristarkhova, M. Weil, N. Ng, K.J. Nelson, A. Lee, H. Zheng, W.M. Kuhtreiber, D.L. Faustman, Bacillus Calmette-Guerin ‘s beneficial impact on glucose metabolism: evidence for broad based applications. iScience 24(10), 103150 (2021). https://doi.org/10.1016/j.isci.2021.103150ADSCrossRefPubMedPubMedCentral

84.

P.L. Tran, J.H. Kim, Y.H. Jung, D.C. Lee, J.U. Choi, D.N. Le, J.W. Nam, M. Shrestha, J.Y. Kim, T.T. Pham, J.H. Jeong, Prolongation of graft survival via layer-by-layer assembly of collagen and immunosuppressive particles on pancreatic islets. Biomaterials 290, 121804 (2022). https://doi.org/10.1016/j.biomaterials.2022.121804CrossRefPubMed

85.

A. Stylianou, V. Gkretsi, M. Louca, L.C. Zacharia, T. Stylianopoulos, Collagen content and extracellular matrix cause cytoskeletal remodelling in pancreatic fibroblasts. J. R. Soc. Interface 16(154), 20190226 (2019). https://doi.org/10.1098/rsif.2019.0226CrossRefPubMedPubMedCentral

86.

S.M. Swain, J.M. Romac, S.R. Vigna, R.A. Liddle, Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice. JCI Insight 7(8), 158288 (2022). https://doi.org/10.1172/jci.insight.158288CrossRef

87.

C.X. Li, L.H. Cui, Y.Z. Zhuo, J.G. Hu, N.Q. Cui, S.K. Zhang, Inhibiting autophagy promotes collagen degradation by regulating matrix metalloproteinases in pancreatic stellate cells. Life Sci. 208, 276–283 (2018). https://doi.org/10.1016/j.lfs.2018.07.049CrossRefPubMed

88.

M. Zheng, H. Li, L. Sun, D.R. Brigstock, R. Gao, Interleukin-6 participates in human pancreatic stellate cell activation and collagen I production via TGF-beta1/Smad pathway. Cytokine 143, 155536 (2021). https://doi.org/10.1016/j.cyto.2021.155536CrossRefPubMed

89.

S.K. Zhang, N.Q. Cui, Y.Z. Zhuo, J.G. Hu, J.H. Liu, D.H. Li, L.H. Cui, Modified Xiaochaihu decoction () promotes collagen degradation and inhibits pancreatic fibrosis in chronic pancreatitis rats. Chin. J. Integr. Med. 26(8), 599–603 (2020). https://doi.org/10.1007/s11655-017-2413-0CrossRefPubMed

90.

M.A. Shields, S. Dangi-Garimella, A.J. Redig, H.G. Munshi, Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochem. J. 441(2), 541–552 (2012). https://doi.org/10.1042/BJ20111240CrossRefPubMed

91.

M.H. Sherman, R.T. Yu, D.D. Engle, N. Ding, A.R. Atkins, H. Tiriac, E.A. Collisson, F. Connor, T. Van Dyke, S. Kozlov, P. Martin, T.W. Tseng, D.W. Dawson, T.R. Donahue, A. Masamune, T. Shimosegawa, M.V. Apte, J.S. Wilson, B. Ng, S.L. Lau, J.E. Gunton, G.M. Wahl, T. Hunter, J.A. Drebin, P.J. O’Dwyer, C. Liddle, D.A. Tuveson, M. Downes, R.M. Evans, Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 159(1), 80–93 (2014). https://doi.org/10.1016/j.cell.2014.08.007CrossRefPubMedPubMedCentral

92.

A. Zinger, L. Koren, O. Adir, M. Poley, M. Alyan, Z. Yaari, N. Noor, N. Krinsky, A. Simon, H. Gibori, M. Krayem, Y. Mumblat, S. Kasten, S. Ofir, E. Fridman, N. Milman, M.M. Lubtow, L. Liba, J. Shklover, J. Shainsky-Roitman, Y. Binenbaum, D. Hershkovitz, Z. Gil, T. Dvir, R. Luxenhofer, R. Satchi-Fainaro, A. Schroeder, Collagenase nanoparticles enhance the penetration of drugs into pancreatic tumors. ACS Nano 13(10), 11008–11021 (2019). https://doi.org/10.1021/acsnano.9b02395CrossRefPubMedPubMedCentral

93.

T. Kaido, M. Yebra, V. Cirulli, A.M. Montgomery, Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. J. Biol. Chem. 279(51), 53762–53769 (2004). https://doi.org/10.1074/jbc.M411202200CrossRefPubMed

94.

C.S. Wegner, J.V. Gaustad, L.M. Andersen, T.G. Simonsen, E.K. Rofstad, Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content. J. Transl. Med. 14(1), 161 (2016). https://doi.org/10.1186/s12967-016-0920-yCrossRefPubMedPubMedCentral

95.

K.H. Bond, T. Chiba, K.P.H. Wynne, C.P.H. Vary, S. Sims-Lucas, J.M. Coburn, L. Oxburgh, The extracellular matrix environment of clear cell renal cell carcinoma determines cancer associated fibroblast growth. Cancers 13(23), 5873 (2021). https://doi.org/10.3390/cancers13235873CrossRefPubMedPubMedCentral

Titel: The collagen matrix regulates the survival and function of pancreatic islets
verfasst von: Yingying Zhu
Mei Yang
Wanli Xu
Yun Zhang
Linlin Pan
Lina Wang
Furong Wang
Yanting Lu
Publikationsdatum: 24.11.2023
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2024
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-023-03592-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The collagen matrix regulates the survival and function of pancreatic islets

Abstract

Graphical Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Graphical Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2024

Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool

Diabetes in a Weiss-Kruszka syndrome boy and a de novo deletion in 9q31.2

Changes of B cell subsets in different types of diabetes and its effect on the progression of latent autoimmune diabetes in adults

Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion

Rates of diagnostic and therapeutic procedures in a cohort of patients undergoing first endocrine consultation for thyroid nodular disease

Impaired thyroid hormone sensitivity increases the risk of papillary thyroid cancer and cervical lymph node metastasis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin